Statement by Fullerton Health in response to CNA Article Dated 7 Dec 2023
In regard to this incident referred to by the CNA article “Company CEO allegedly took S$240,000 in bribes from Fullerton Healthcare Group” dated 7 December 2023, it was Fullerton Health’s governance structures that first afforded a whistle-blower the avenue to raise this incident to management.
Fullerton Health Fully Owned (FFO) Specialist Division Expands to include Endocrinology
Diabetes and Endocrine disorders are one of the top health conditions amongst the Fullerton Health Group (FHG) network members. To bolster the FHG medical offerings, the FFO Specialist Division is delighted to announce the addition of Endocrinology.
